Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.4.2.8 (
hypoxanthine-guanine phosphoribosyltransferase
)
2,527
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Styrene-7,8-oxide (SO) is a highly reactive epoxide able to undergo reactions with endogenous nucleophiles, such as DNA. SO is inactivated by
glutathione-S-transferase M1
(
GSTM1
). This detoxification enzyme is absent in approximately one-half of Caucasian (49%) populations. A
GSTM1
recombinant human lymphoblastoid cell line (FB7) was generated from a
GSTM1
negative parental cell line (WIL2NS).
GSTM1
status was determined using RT-PCR and immunochemistry. Cells were challenged with a range of SO doses and subsequent toxicity (population growth in flasks) and genotoxicity (mutations at the
HPRT
locus) were monitored. FB7 (
GSTM1
positive) exhibited greater cell survival after SO exposure relative to the
GSTM1
negative parental line. The IC50 following a 1 h exposure to SO was 0.5 mM for WIL2NS, compared to greater than 2.5 mM for FB7. The extrapolated IC50 for FB7 was 5.5 mM. Significantly fewer mutant cells were induced by SO for FB7 than for WIL2NS at equivalent doses of SO. These findings suggest that the sensitivity of cells to styrene-7,8-oxide is influenced by
GSTM1
status and that a recombinant
GSTM1
positive cell line can efficiently detoxify styrene-7,8-oxide.
...
PMID:A recombinant model for assessing the role of GSTM1 in styrene-7,8-oxide toxicity and mutagenicity. 1469 68